TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Jenving Clinical Trial Services AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
104
|
112
|
150 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
33
|
28
|
50 |
EBITDA |
31
|
28
|
51 |
Total assets |
162
|
185
|
211 |
Current assets |
136
|
172
|
199 |
Current liabilities |
6
|
9
|
18 |
Equity capital |
147
|
153
|
168 |
- share capital |
4
|
5
![]() |
5 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
90.7%
|
82.7%
|
79.6% |
Turnover per employee |
104
|
112
|
150 |
Profit as a percentage of turnover |
31.7%
|
25.0%
|
33.3% |
Return on assets (ROA) |
20.4%
|
15.1%
|
23.7% |
Current ratio |
2266.7%
|
1911.1%
|
1105.6% |
Return on equity (ROE) |
22.4%
|
18.3%
|
29.8% |
Change turnover |
1
|
-35
|
3 |
Change turnover % |
1%
|
-24%
|
2% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.